About OXY99
OXY99 is a Healthcare company. Production of portable oxygen cans for health, emergencies, and altitude uses in India. Its Indian entity Zeneris Pharma Private Limited reported revenue of ₹3.50 Cr. OXY99 offers products and services including OXY99 Oxygen Cans and Oxygen Therapy Solutions. Its focus areas include Consumer Goods, Health Supplements, Oxygen Supplements and Pharmaceuticals.
Company details
OXY99 is manufactured by Zeneris Pharma Pvt. Ltd. and is recognized for supplying portable oxygen cans that deliver up to 150 inhalations per unit, primarily for respiratory aid in emergencies, high altitude scenarios, sports, and to boost energy levels. The product features a 99 oxygen formula, which is independently tested for antimicrobial properties, helping to combat anaerobic microbes. It is made available through distributors and direct sales, emphasizing its role in enhancing oxygen availability at the cellular level for therapeutic benefits, with applications extending to everyday freshness and health support.
- SectorsHealthcare
- Email••••••••
- Legal Name Zeneris Pharma Pvt. Ltd
- Date of Incorporation 08 Jul, 2016
- Jurisdiction New Delhi, Delhi, India
- Indian entity revenue₹3.50 Cr
FY 2025 · +74% YoY
- Indian entity net profit₹30 Lakh
FY 2025 · 9% margin
- Indian entity EBITDA₹29.7 Lakh
FY 2025 · 9% margin
Associated legal entities of OXY99
OXY99 operates through Zeneris Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Zeneris Pharma Private Limited CIN U33100DL2016PTC302689 | Active | 08 Jul 2016 | New Delhi, Delhi | ₹3.5 Cr | 2 | View details |
Products & Services of OXY99
OXY99 offers a comprehensive portfolio of products and services, including OXY99 Oxygen Cans and Oxygen Therapy Solutions.
Portable oxygen bottles are provided for inhalation in emergencies and daily use, offering up to 150 inhalations per can.
Oxygen therapy is supplied for high altitude and sports applications, with formulations that are tested for antimicrobial effects.
Board of directors of Zeneris Pharma Private Limited (OXY99)
Zeneris Pharma Private Limited is the primary company behind OXY99. The board of Zeneris Pharma Private Limited currently have 2 directors; the longest-serving is Aditya Agrawal, appointed in 2016. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Aditya Agrawal DIN 05250489 | Director | 08 Jul 2016 | 10 yrs 3 mo | Zeneris Pharma Private Limited |
| Rashi Dixit DIN 00007115 | Director | 30 Mar 2024 | 2 yrs 6 mo | Zeneris Pharma Private Limited |
Financials of OXY99
Figures of Zeneris Pharma Private Limited, the primary company behind OXY99, for FY 2025. Revenue was ₹3.50 Cr (+74% year on year). Net profit was ₹30 Lakh (9% margin). EBITDA was ₹29.7 Lakh (9% margin). Revenue has grown at a compounded annual rate of -19% over three years and +27% over five years.
- ₹3.50 CrRevenue · FY 2025 · +74% YoY
- ₹30 LakhNet profit · 9% margin
- ₹29.7 LakhEBITDA · 9% margin
- ₹1 LakhPaid-up capital
- -19%Revenue CAGR, 3 years
- +27%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Zeneris Pharma Private Limited are on its company page.
Detailed financial statements for OXY99
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about OXY99
The primary company behind OXY99, Zeneris Pharma Private Limited, reported revenue of ₹3.50 Cr for FY 2025, up 74% year on year.
OXY99 is manufactured by Zeneris Pharma Pvt. Ltd. and is recognized for supplying portable oxygen cans that deliver up to 150 inhalations per unit, primarily for respiratory aid in emergencies, high altitude scenarios, sports, and to boost energy levels. The product features a 99 oxygen formula, which is independently tested for antimicrobial properties, helping to combat anaerobic microbes. It is made available through distributors and direct sales, emphasizing its role in enhancing oxygen availability at the cellular level for therapeutic benefits, with applications extending to everyday freshness and health support.
OXY99 offers OXY99 Oxygen Cans and Oxygen Therapy Solutions.
OXY99 operates through Zeneris Pharma Private Limited.
The legal entities of OXY99 currently have 2 directors, including Aditya Agrawal, Rashi Dixit.